Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
2037
result was found. Results that relate to
M
Efficacy of edaravone dexborneol combined with alteplase in the treatment of acute ischemic stroke: a randomized controlled trial
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):978-985.
12582 times
2049 times
WU Weijie
SUN Zihui
XU Liang’e
HUANG He
HUANG Xuerong
Edaravone dexborneol
Alteplase
Acute ische
m
ic stroke
Intravenous thro
m
bolysis
Efficacy
Details
Correlation analysis between PPIs and prognosis of AECOPD patients based on MIMIC-Ⅳ database: a retrospective cohort study
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):986-992.
12126 times
1857 times
WANG Yuan
XIN Caixia
YANG Haiying
CHEN Dan
HUANG Na
Chronic obstructive pul
m
onary disease
Acute exacerbation
Proton pu
m
p inhibitor
Prognosis
M
I
M
IC-Ⅳ Database
Details
Research of medication rules and multi-pathway mechanism of action in the treatment of vitiligo by traditional Chinese medicine compound patent
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):993-1005.
13344 times
1920 times
DONG Xiaoyi
JIANG Deyou
WANG Zeyun
MENG Yuxi
MIN Zongfu
ZHANG Xuan
WANG Shaoying
WANG Yuanhong
Vitiligo
Traditional Chinese
M
edicine co
m
pound patent
Network phar
m
acology
M
olecular docking
M
edication rules
M
echanis
m
s of action
Details
Exploring the mechanism of Xiaoshi Lidan pills in the treatment of cholelithiasis based on network pharmacology and UPLC-MS/MS
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1006-1016.
12034 times
1914 times
YUAN Mingyang
FU Jinzhou
HUANG Zhongqiang
YAN Hongmei
ZHANG Yisheng
LI Juan
Xiaoshi Lidan pills
Cholelithiasis
Che
m
ical co
m
position
UPLC-
M
S/
M
S
Network phar
m
acology
Details
CDK4/6 inhibitors in the first-line treatment of HR+/HER2- advanced stage breast cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1017-1029.
11919 times
1856 times
LI Anna
XIA Zhengzheng
CAI Jiali
LIAN Zhuoshi
MENG Jun
CDK4/6 inhibitors
Endocrine therapy
HR+/HER2- advanced breast cancer
Rapid health technology assess
m
ent
Details
Four intravenous iron formulations in the treatment of iron deficiency anemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1030-1043.
12735 times
1990 times
XING Zhicong
SUN Fudong
XUE Qingxia
ZHANG Bei
MU Shengjun
ZHAO Quan
Iron sucrose
Iron dextran
Ferric carboxy
m
altose
Iron iso
m
altoside
Iron deficiency anae
m
ia
Rapid health technology assess
m
ent
Details
HLA-B*5801 gene polymorphisms detection in prediction of severe drug eruption associated allopurinol: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1044-1053.
11561 times
1864 times
CAO Jinjin
LING Ya
ZHANG Jie
ZHANG Jingjing
ZHU Jianguo
CAO Xiufang
Allopurinol
HLA-B*5801 gene testing
Severe drug eruption
Rapid health technology assess
m
ent
Details
Bibliometric analysis of active surveillance of post-marketing drug safety
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1054-1063.
12848 times
2004 times
WANG Conghui
YANG Ziming
WANG Zhenxing
SHI Wei
ALATENG Hua
XI Chengwei
PI Songning
YUAN Xinmin
ZHAN Siyan
Surveillance of post-
m
arketing safety of drugs
Active surveillance
Phar
m
acovigilance
Biblio
m
etrics
Visualization analysis
Details
Research status and hotspot analysis of leech in the field of medicine based on bibliometrics
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1064-1073.
14690 times
2245 times
XIN Quancheng
ZHANG Yanzhao
HUA Yutong
GUO Xiuhuan
SU Zhaoyuqing
LIU Chuanxin
YUAN Ruijuan
Leech
Biblio
m
etrics
Visual analysis
Hotspot and trend
Living application
Details
Clinical pharmacists participated in the drug therapy and pharmaceutical care of a patient with Crohn's disease complicated with erythema multiforme
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1074-1080.
11309 times
1856 times
LI Binbin
XU Cuilin
HU Naizhong
REN Xiaofei
WANG Yanyan
Crohn's disease
Erythe
m
a
m
ultifor
m
e
Inflixi
m
ab
Ustekinu
m
ab
Extraintestinal
m
anifestations
Phar
m
aceutical care
Details
The regulatory effect of Huangzhi oral liquid on hepatocyte apoptosis and ferroptosis in acute hyperlipidemia mice based on abnormal lipid metabolism
Published on
Frontiers in Pharmaceutical Sciences
2024,28(1):2-11.
9157 times
1358 times
ZHANG Zhe
PANG Xiaoyan
NIU Mengyuan
DAI Weibo
ZENG Congyan
Huangzhi oral liquid
Lipid
m
etabolis
m
Ferroptosis
Apoptosis
Acute hyperlipide
m
ia
Details
Mechanism of Yupingfeng granules for recurrent respiratory tract infections in children based on network pharmacology
Published on
Frontiers in Pharmaceutical Sciences
2024,28(1):12-19.
10062 times
1541 times
HONG Qiuyue
KUANG Qi
WU Jun
Yupingfeng granule
Recurrent respiratory tract infection
M
olecular
m
echanis
m
Network Phar
m
acology
Go enrich
m
ent analysis
KEGG enrich
m
ent analysis
Details
The optimal blood concentration range of tacrolimus for the treatment of nephrotic syndrome in children
Published on
Frontiers in Pharmaceutical Sciences
2024,28(1):20-27.
10079 times
1675 times
YIN Meina
MENG Yan
LIU Ling
Tacroli
m
us
Nephrotic syndro
m
e
Blood concentration
Children
Receiver operator characteristic curve
Adverse effects
Details
Effects of statins on survival outcomes in patients with metastatic renal cell carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,28(1):28-33.
8854 times
1246 times
GAO Shiliang
HE Xiaoqi
ZHENG Huijie
YANG Di
YU Mingzhu
M
etastatic renal cell carcino
m
a
Statins
Survival outco
m
es
Overall survival
Progression-free survival
Objective response rate
Disease control rate
Details
Effect of denosumab versus alendronate on periprosthetic bone mineral density after total hip arthroplasty
Published on
Frontiers in Pharmaceutical Sciences
2024,28(1):34-40.
9354 times
1340 times
FU Weicong
WANG Tianbao
LI Xiaofei
Denosu
m
ab
Bone
m
ineral density
Periprosthetic bone loss
Total hip arthroplasty
Bisphosphonate
Details
上一页
1
2
66
67
68
69
70
71
72
135
136
下一页